Novel microfilaricidal activity of nanosilver

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1023-1030

  Singh, Sunil K ^a   Goswami, Kalyan ^b   Sharma, Richa D ^b   Reddy, Maryada V R ^b   Dash, Debabrata ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b MAHATMA GANDHI INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Lymphatic filariasis; Microfilaricidal agent; Parasitic diseases; Silver nanoparticles

Indexed keywords

ACRIDINE ORANGE; ETHIDIUM BROMIDE; GOLD NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SILVER NANOPARTICLE; STAUROSPORINE; TRYPAN BLUE; ANTIFILARIAL AGENT; ETHIDIUM; GOLD; METAL NANOPARTICLE; SILVER;

ANTHELMINTIC ACTIVITY; APOPTOSIS; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; DRUG EFFICACY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GROWTH INHIBITION; LYMPHATIC FILARIASIS; MERIONES UNGUICULATUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARASITE TRANSMISSION; PARTICLE SIZE; RODENT; STAINING; ANIMAL; CHEMISTRY; DRUG EFFECT; FILARIASIS; GERBIL; METABOLISM; PARASITOLOGY; REPRODUCIBILITY;

BRUGIA MALAYI; EUKARYOTA; MERIONES; MERIONES UNGUICULATUS;

ACRIDINE ORANGE; ANIMALS; APOPTOSIS; BRUGIA MALAYI; ETHIDIUM; FILARIASIS; FILARICIDES; GERBILLINAE; GOLD; METAL NANOPARTICLES; PARTICLE SIZE; POLY(ADP-RIBOSE) POLYMERASES; REPRODUCIBILITY OF RESULTS; SILVER;

EID: 84862322567     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28758     Document Type: Article

References (40)

1. Ottesen EA, Duke BO, Karam M, Behbehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491-503.
2. Fan PC. Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects. Ann Trop Med Parasitol. 1992;86(4):399-405.
3. Tropical Diseases, Special Programme for Research and Training (TDR). Strategic direction for lymphatic filariasis research: disease burden and epidemiological trends [article on the Internet]. Geneva: TDR; 2012. Available from: http://www.who.int/tdr/diseases/lymphfil/direction/en/ index.html. Accessed February 3, 2012.
4. World Health Organization. Defining the roles of vector control and xenomonitoring in the Global Programme to Eliminate Lymphatic Filariasis. Report of the informal consultation; January 29-31, 2002; Geneva, Switzerland. Geneva: World Health Organization; 2002. Document: WHO/CDS/CPE/PVC/2002.3.
5. Indian Council of Medical Research. Prospects of elimination of lymphatic filariasis in India. ICMR Bull. 2002;32(5-6):1-14.
6. McGarry HF, Plant LD, Taylor MJ. Diethylcarbamazine activity against Brugia malayi microfilariae is dependent on inducible nitricoxide synthase and the cyclooxygenase pathway. Filaria J. 2005;4:4-12.
7. Verhasselt V, Goldman M, Willems F. Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells. Eur J Immunol. 1998;28(11):3886-3890.
8. Sahare KN, Anandharaman V, Meshram VG, et al. Anti-microfilarial activity of methanolic extract of Vitex negundo and Aegle marmelos and their phytochemical analysis. Indian J Exp Biol. 2008;46(2): 128-131.
9. Bag S, Tawari NR, Sharma R, Goswami K, Reddy MV, Degani MS. In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies. Acta Trop. 2010;113(1): 48-51.
10. Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3(1):95-101.
11. Shrivastava S, Bera T, Roy A, Singh G, Ramchandrarao P, Dash D. Characterization of enhanced antibacterial effect of novel silver nanoparticles. Nanotechnology. 2007;18(22):225103-225111.
12. Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology. 2008;19(7):075104-075113.
13. Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh SS. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf B Biointerfaces. 2010;77(2):240-245.
14. Foldbjerga R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190(2):156-162.
15. Miura N, Shinohara Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun. 2009;390(3):733-737.
16. AshaRani PV, Low Kuh Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-290.
17. Peixoto CA, Santos AC, Ayres CF. Molecular evidence for apoptosis in microfilariae of Wuchereria bancrofti induced by diethylcarbamazine. Parasitol Res. 2008;103(3):717-721.
18. Barcinski MA, DosReis GA. Apoptosis in parasites and parasite-induced apoptosis in the host immune system: a new approach to parasitic diseases. Braz J Med Biol Res. 1999;32(4):395-401.
19. Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano. 2009;3(6):1357-1364.
20. Shrivastava S, Singh SK, Mukhopadhyay A, Sinha AS, Mandal RK, Dash D. Negative regulation of fibrin polymerization and clot formation by nanoparticles of silver. Colloids Surf B Biointerfaces. 2011;82(1):241-246.
21. Okuya S, Tanabe K, Tanizawa Y, Oka Y. Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology. 2001;142(11):4827-4830.
22. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5:12-19.
23. Alves LC, Brayner FA, Silva LF, Peixoto CA. The ultrastructure of infective larvae (L3) of Wuchereria bancrofti after treatment with diethylcarbamazine. Micron. 2005;36(1):67-72.
24. Mullen P. PARP cleavage as a means of assessing apoptosis. In: Langdon SP, editor. Cancer Cell Culture: Methods and Protocols. Totowa, NJ: Humana Press; 2004:171-181.
25. Böhm I. The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus. Z Rheumatol. 2006;65(6): 541-544. German.
26. Mackenzie CD, Kron MA. Diethylcarbamazine: a review of its action in onchocerciasis, lymphatic filariasis and inflammation. Trop Dis Bull. 1985;82:R1-R36.
27. Smith VP, Selkirk ME, Gounaris K. Brugia malayi: resistance of cuticular lipids to oxidant-induced damage and detection of l-tocopherol in the neutral lipid fraction. Exp Parasitol. 1998;88(2):103-110.
28. Sharma RD, Janardhana PB, Gajalakshmi D, Reddy MV, Goswami K. Novel pharmaceutical rationale against human lymphatic filariasis: an oxidative premise. Asian Pac J Trop Med. 2009;2(1):30-34.
29. Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):2346-2353.
30. Hwang ET, Lee JH, Chae YJ, et al. Analysis of the toxic mode of action of silver nanoparticles using stress-specific bioluminescent bacteria. Small. 2008;4(6):746-750.
31. Choi O, Deng KK, Kim NJ, Ross L Jr, Surampalli RY, Hu Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008;42(12):3066-3074.
32. Matsumura Y, Yoshikata K, Kunisaki S, Tsuchido T. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol. 2003;69(7):4278-4281.
33. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater. 2010;22(16):4548-4554.
34. Nandha B, Sadanandane C, Jambulingam P, Das P. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J. 2007;6:7-12.
35. Maizels RM, Denham DA. Diethylcarbamazine (DEC): immunopharmacological interactions of an antifilarial drug. Parasitology. 1992;105 Suppl:S49-S60.
36. Allahverdiyev AM, Abamor ES, Bagirova M, et al. Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomedicine. 2011;6:2705-2714.
37. Buttke TM, Sandstrom PA. Oxidative stress as a mediator for apoptosis. Immunol Today. 1994;15(1):7-10.
38. Lankveld DP, Oomen AG, Krystek P, et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials. 2010;31(32):8350-8361.
39. El-Ansary A, Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol. 2009;2009:754810-754818.
40. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol. 2011;45(1):283-287.